We are live on ! Find out more
NDSI

Newman Dignan & Sheerar Inc Portfolio holdings

AUM $523M
1-Year Est. Return 26.16%
This Fund
S&P 500
This Quarter Est. Return
-2.78%
1 Year Est. Return
+26.16%
3 Year Est. Return
+73.46%
5 Year Est. Return
+76.54%
10 Year Est. Return
+279.61%
AUM
$638K
AUM Growth
-$292M
Cap. Flow
-$3.04M
Cap. Flow %
-476.52%
Top 10 Hldgs %
70.08%
Holding
195
New
15
Increased
81
Reduced
55
Closed
9

Top Buys

Rank Stock Value
1
DFAE icon
Dimensional Emerging Core Equity Market ETF
DFAE
+$1.79M
2
IBMN
iShares iBonds Dec 2025 Term Muni Bond ETF
IBMN
+$832K
3
IBMM
iShares iBonds Dec 2024 Term Muni Bond ETF
IBMM
+$808K
4
IBMO icon
iShares iBonds Dec 2026 Term Muni Bond ETF
IBMO
+$747K
5
IBML
iShares iBonds Dec 2023 Term Muni Bond ETF
IBML
+$688K

Top Sells

Rank Stock Value
1
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$3.74M
2
SCHZ icon
Schwab US Aggregate Bond ETF
SCHZ
+$1.02M
3
FPE icon
First Trust Preferred Securities and Income ETF
FPE
+$867K
4
FIXD icon
First Trust Smith Opportunistic Fixed Income ETF
FIXD
+$806K
5
GSIE icon
Goldman Sachs ActiveBeta International Equity ETF
GSIE
+$781K

Sector Composition

Rank Sector Weight
1 Financials 59.26%
2 Technology 4.82%
3 Healthcare 3.94%
4 Industrials 1.89%
5 Communication Services 1.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OR icon
176
OR Royalties Inc
OR
$6.2B
$108 0.02%
+10,639
New +$107K
CLSD
177
DELISTED
Clearside Biomedical
CLSD
$31 ﹤0.01%
+1,802
New +$39.5K
OVID icon
178
Ovid Therapeutics
OVID
$491M
$29 ﹤0.01%
+15,522
New +$32.5K
TCRR
179
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$21 ﹤0.01%
+11,522
New +$33.4K
ONCY
180
Oncolytics Biotech
ONCY
$95.8M
$16 ﹤0.01%
+12,915
New +$15.8K
MIR.WS
181
DELISTED
Mirion Technologies, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MIR.WS
$15 ﹤0.01%
+10,023
New +$13.6K
MDNA
182
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$11 ﹤0.01%
+12,915
New +$14.6K
APTO
183
DELISTED
Aptose Biosciences, Inc.
APTO
$11 ﹤0.01%
+42
New +$14.5K
SLDB icon
184
Solid Biosciences
SLDB
$900M
$7 ﹤0.01%
+1,002
New +$10.1K
DSS icon
185
DSS Inc
DSS
$5.13M
$4 ﹤0.01%
+836
New +$5.38K
OGEN icon
186
Oragenics
OGEN
$2.48M
$2 ﹤0.01%
+6
New +$3.5K
FNDE icon
187
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$9.81B
– –
-12,260
Closed -$318K
IEMG icon
188
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
– –
-76,233
Closed -$3.74M
NOW icon
189
ServiceNow
NOW
$129B
– –
-2,220
Closed -$211K
SCHE icon
190
Schwab Emerging Markets Equity ETF
SCHE
$12.9B
– –
-10,726
Closed -$272K
SHY icon
191
iShares 1-3 Year Treasury Bond ETF
SHY
$25.1B
– –
-4,677
Closed -$387K
SPLV icon
192
Invesco S&P 500 Low Volatility ETF
SPLV
$7.21B
– –
-4,428
Closed -$275K
SUB icon
193
iShares Short-Term National Muni Bond ETF
SUB
$11.4B
– –
-2,716
Closed -$284K
SWK icon
194
Stanley Black & Decker
SWK
$15.7B
– –
-3,648
Closed -$383K
UL icon
195
Unilever
UL
$136B
– –
-3,911
Closed -$202K
4 5 6 7
8

Similar funds

SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
ETS
ESL Trust Services Rochester, New York $524M AUM 17.18% 1-Year Est. Return
CM
Conifer Management New York $524M AUM 14.11% 1-Year Est. Return
SRFM
Shannon River Fund Management New York $524M AUM 90.54% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
DA
Drake & Associates Waukesha, Wisconsin $525M AUM 14.04% 1-Year Est. Return
CFM
Crawford Fund Management Boston, Massachusetts $520M AUM 14.79% 1-Year Est. Return
CI
CacheTech Inc Logan, Utah $519M AUM 22.06% 1-Year Est. Return

Newman Dignan & Sheerar Inc's Q3 2022 Portfolio in Review

As of Q3 2022, Newman Dignan & Sheerar Inc held 195 positions worth $638K, down 100% from $293M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Newman Dignan & Sheerar Inc withdrew a net $3.04M in Q3 2022, closing 9 positions and reducing 55 holdings. Its most notable exit was iShares Core MSCI Emerging Markets ETF, an estimated $3.74M position sold in full.

By sector, the portfolio is most concentrated in Financials at 59% of assets, up from 4.4% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Newman Dignan & Sheerar Inc opened a new position in Independent Bank worth $346.

  • Newman Dignan & Sheerar Inc's largest Q3 2022 buy was Independent Bank: 4,637 shares worth $346.
  • Newman Dignan & Sheerar Inc added most to Dimensional Emerging Core Equity Market ETF in Q3 2022, an estimated $1.79M increase.
  • Newman Dignan & Sheerar Inc's biggest Q3 2022 reduction was Schwab US Aggregate Bond ETF, cutting an estimated $1.02M.
  • Newman Dignan & Sheerar Inc fully exited iShares Core MSCI Emerging Markets ETF in Q3 2022, selling an estimated $3.74M.
  • Newman Dignan & Sheerar Inc's ten largest holdings make up 70% of its $638K portfolio in Q3 2022.
  • Newman Dignan & Sheerar Inc opened 15 new positions and closed 9 in Q3 2022.
  • Newman Dignan & Sheerar Inc's portfolio value fell 100% quarter-over-quarter to $638K.

Based on Newman Dignan & Sheerar Inc's 13F filing for Q3 2022, filed 18 Oct 2022.